课题基金 / 基金详情

PATHOBIOLOGY OF FOAM CELLS IN ATHEROSCLEROSIS

PATHOBIOLOGY OF FOAM CELLS IN ATHEROSCLEROSIS
动脉粥样硬化中泡沫细胞的病理学
批准号:
3074210
负责人:
DOMENICK J FALCONE
金额:
$5.34万
依托单位国家:
美国
项目类别:
财政年份:
1987
资助国家:
美国
项目状态:
已结题
起止时间:
1987-04-01 至 1992-03-31

项目摘要

项目成果

DOMENICK J FALCONE的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The emigration of monocytes from the circulation to a subendothelial position, and their subsequent transformation into cholesteryl ester rich foam cells is one of the earliest recognizable processes in lesion formation. In proposed experiments, aspects of macrophage function thought to play a role in vascular biology will be assessed. In particular, we will investigate macrophage-derived foam cells' release and/or activation of extracellular proteases. Secretion of soluble plasminogen activator and expression of membrane associated activator will be determined. The activity of other neutral proteases will also be assessed including that of collagenase. In addition to the important role of macrophage in connective tissue degradation and fibrinolysis, macrophage also activate proteases involved in coagulation. Therefore, the elaboration of procoagulant activity by macrophage-derived foam cells will be determined. Utilizing these parameters, the relationship the cell's state of activation and its subsequent response to lipid and/or lipoprotein accumulation will be investigated. Finally, the effect of soluble foam cell factors on a variety of endothelial and smooth muscle cell properties important to vascular homeostasis will be investigated. These include plasminogen activator/inhibitor activities, release of collagenase, degradation of cell-derived matrix, expression of procoagulant activity and reactivity to monocytes. Elucidation of how macrophage-derived foam cells may directly or indirectly contribute to or modulate these processes by other cells will contribute significantly to our understanding of lesion progression.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PGE2 receptors: therapeutic targets in occlusive and aneurysmal vascular diseases
PGE2 receptors as therapeutic targets in occlusive and aneurysmal vascular diseas
PGE2 receptors: therapeutic targets in occlusive and aneurysmal vascular diseases
PGE2 receptors as therapeutic targets in occlusive and aneurysmal vascular diseas
海外基金